Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical) has announced the addition of the "Biopharmaceutical Bioseparation Systems - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 52 companies including many key and niche players such as:
- 3M Company (US)
- 3M Purification, Inc. (US)
- Agilent Technologies, Inc. (US)
- Alfa Wassermann Separation Technologies, LLC (US)
- Flottweg Separation Technology (US)
- GEA Westfalia Separator Group GmbH (Germany)
- GE Healthcare (UK)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- Konik Nanobiotech SL (Spain)
- Merck KGaA (Germany)
- NuSep Holdings Ltd. (Australia)
- Pall Corporation (US)
- ProMetic Life Sciences, Inc. (Canada)
- Sartorius Stedim Biotech (France)
- Spectrum Laboratories, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Tosoh Bioscience, Inc. (Japan)
- YMC Europe GmbH (Germany)
Key Topics Covered:
1. Outlook
2. Industry Overview
3. Bioseparation Technologies - Key Trends
4. Product Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (32)
- Canada (1)
- Japan (5)
- Europe (18)
- - France (3)
- - Germany (9)
- - The United Kingdom (1)
- - Spain (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Google Secures Pentagon AI Deal for Classified Projects
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 



